More on GNPX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (6.7 Score)
- Holders

Upcoming Events

- Earnings (11/17/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Genprex (NQ:GNPX)
Delayed: 8.01 +0.80 (11.10%)
Prev. Close $7.21  
Open$7.18 
52 Wk High$ 
52 Wk Low$ 
Day High$8.17 
Day Low$6.99 
P/E N/A  
EPS$ 
Volume14,932 


Jul 14, 2026 09:23 AM Form 8-K Genprex, Inc. For: Jul 13
Jun 26, 2026 04:46 PM Form S-8 Genprex, Inc.
Jun 22, 2026 09:02 AM Form 8-K Genprex, Inc. For: Jun 22
Jun 22, 2026 09:00 AM Genprex receives Canadian patent notice for Reqorsa combo therapy
Jun 22, 2026 09:00 AM Genprex Receives a Notice of Allowance from The Canadian Intellectual Property Office for a Patent Claiming the Combination of Reqorsa® Gene Therapy with Either PD-1 or PD-L1 Antibodies to Treat Canc
Jun 18, 2026 04:01 PM Form 8-K Genprex, Inc. For: Jun 18
Jun 17, 2026 09:02 AM Genprex to Participate at BIO International Convention 2026
Jun 12, 2026 05:06 PM Form 8-K Genprex, Inc. For: Jun 10
Jun 5, 2026 05:04 PM Genprex (GNPX) files for $250M mixed shelf
Jun 5, 2026 05:02 PM Form S-3 Genprex, Inc.
View All Articles

Entities mentioned with GNPX

View All Entities